H. U. Schorlemmer
- Immunology top 5%
- Molecular Biology
- Surgery top 10%
- Oncology top 10%
- Hematology top 5%
- Co-authors
- A. C. AllisonR. KurrleD Bitter-SuermannR. R. BartlettJ. FerlugaKlaus BossletHans PrydzP.A. Davies
- Topics
- Monoclonal and Polyclonal Antibodies Research (13 papers)Biochemical and Molecular Research (12 papers)Complement system in diseases (10 papers)
- Cited by
- TransplantationImmunologyPhysiology
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
H. U. Schorlemmer
101 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 105
- Immunology 751
- Molecular Biology 608
- Surgery 307
- Oncology 266
- Hematology 217
Countries citing papers authored by H. U. Schorlemmer
This map shows the geographic impact of H. U. Schorlemmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. U. Schorlemmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. U. Schorlemmer more than expected).
Fields of papers citing papers by H. U. Schorlemmer
This network shows the impact of papers produced by H. U. Schorlemmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. U. Schorlemmer. The network helps show where H. U. Schorlemmer may publish in the future.
Co-authorship network of co-authors of H. U. Schorlemmer
This figure shows the co-authorship network connecting the top 25 collaborators of H. U. Schorlemmer. A scholar is included among the top collaborators of H. U. Schorlemmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. U. Schorlemmer. H. U. Schorlemmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 5 | |
| 3 | 7 | |
| 4 | 4 | |
| 5 | 3 | |
| 6 | 1 | |
| 7 | 11 | |
| 8 | 0 | |
| 9 | 5 | |
| 10 | 24 | |
| 11 | 12 | |
| 12 | 30 | |
| 13 | 13 | |
| 14 | Effect of malononitrilamides on human bone marrow. | 3 |
| 15 | Control of mouse-to-rat skin xenograft rejection by malononitrilamides. | 6 |
| 16 | 4 | |
| 17 | 31 | |
| 18 | 7 | |
| 19 | 6 | |
| 20 | Production of the complement cleavage product, C3a, by activated macrophages and its tumorolytic effects. | 91 |
About H. U. Schorlemmer
H. U. Schorlemmer is a scholar working on Transplantation, Physiology and Immunology, having authored 110 papers that have together received 2.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (13 papers), Biochemical and Molecular Research (12 papers) and Complement system in diseases (10 papers). The work is most often cited by research in Transplantation (125 citations), Immunology (751 citations) and Physiology (93 citations). H. U. Schorlemmer has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include A. C. Allison, R. Kurrle, D Bitter-Suermann, R. R. Bartlett, J. Ferluga, Klaus Bosslet, Hans Prydz, P.A. Davies, C. Arden Pope and Edward Keystone. Their work appears in journals such as Nature, The Lancet and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.